Surface modifying additives reduce thrombogenicity: An in vitro and clinical evaluation

Cells and Materials

Volumn 7, Issue 3, 1998, Pages 201-208

  Spijker, H T ^b   Haan, J ^b   Graaff, R ^b   Boonstra, P W ^b   Van Oeveren, W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NONE

Author keywords

Biomaterials; Bloodcompatibility; Cardiopulmonary bypass; Clotting activity; Extracorporeal circuit; Fibrinogen binding; Platelets binding; Surface modifying additives; Thrombogenicity

Indexed keywords

BETA THROMBOGLOBULIN; BIOMATERIAL; COPOLYMER; FIBRINOGEN; GLYCOPROTEIN IIIA; POLYSILOXANE; POLYVINYLCHLORIDE; PROTHROMBIN; SURFACE MODIFYING ADDITIVE; THROMBIN; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOCYTE RELEASE REACTION; THROMBOGENICITY; THROMBUS;

EID: 0031758819     PISSN: 10516794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Agam G, Shohat O, Livne A (1985) Fibrinogen fragment D is a recognition site for release-related platelet aggregation. Thromb Res 37: 629-638.
2. Boyle EM, Verrier ED, Spiess BD (1996) Endothelial cell injury in cardiovascular surgery: The procoagulant response. Ann Thorac Surg 62: 1549-1557.
3. Gu YJ, Boonstra PW, Rijnsburger AA, Haan J, van Oeveren W (1998) Cardiopulmonary bypass circuit treated with surface modifying additives (SMA): A clinical evaluation of blood compatibility. Ann Thorac Surg, in press.
4. Köhler AS, Parks PJ, Mooradian DL, Rao GHR, Furcht LT (1996) Platelet adhesion to novel phospholipids materials: Modified phosphatidylcholine covalently immobilized to silica, polypropylene and PTFE materials. J Biomed Mat Res 32: 237-242.
5. Lee JH, Jeong BJ, Lee HB (1997) Plasma protein adsorption and platelet adhesion onto comb-like PEO gradient surfaces. J Biomed Mat Res 34: 105-114.
6. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD (1988) Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 71: 1366-1374.
7. Mondoro TH, Wall CD, White MM, Jennings LK (1996) Selective induction of a Glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor. Blood 88: 3824-3830.
8. Peerschke EIB (1985) The platelet fibrinogen receptor. Semin Haem 22: 241-249.
9. Peerschke EIB (1992) Events occurring after thrombin-induced fibrinogen binding to platelets. Semin Thromb Haemost 18: 34-43.
10. Phillips DR, Charo IF, Parise LV, Fitzgerald LA (1988) The platelet membrane glycoprotein IIb-IIIa complex. Blood 71: 831-843.
11. Rhodes NP, Williams DF (1994) Plasma recalcification as a measure of contact phase activation and heparinization efficacy after contact with biomaterials. Biomaterials 15: 35-37.
12. Salzman EW, Lindon J, McManama G, Ware JA (1987) Role of fibrinogen in activation of platelets by artificial surfaces. Ann NY Acad Sci 516: 184-195.
13. Schlosser E, Simler R, Hörmann H (1993) Retention of thrombin by polytetrafluoroethylene: Influence on the adsorption of fibrinogen/fibrin. Biomaterials 14: 365-370.
14. Tsai C, Deppisch RM, Forrestal LJ, Ritzau GH, Oram AD, Göhl HJ, Voorhees ME (1994) Surface modifying additives for improved device-blood compatibility. ASAIO 40: M619-M624 (ASAIO: American Society for Artificial Internal Organs).
15. Wenger RK, Lukasiewicz H, Mikuta BS, Niewiarowski S, Edmunds LH (1989) Loss of platelet fibrinogen receptors during clinical cardiopulomary bypass. J Thorac Cardiovasc Surg 97: 235-239.
16. Yui N, Okano T, Sakurai Y, Kora S, Ishikawa K, Hiranuma T, Yamashita S (1996) Cytoplasmic calcium levels and membrane fluidity of platelets in contact with poyether-polyamide multiblock-copolymer surfaces. Art Organs 20: 103-108.